- Encouraging activity for CX-2029 in Phase 2 expansion study in squamous non-small cell lung cancer (sqNSCLC) reported in 2021 -
- First-in-human study of CX-904 in advanced solid tumors to be initiated in first half of 2022 -
Read more at globenewswire.com